TMCnet News

Research and Markets: Orthobiologics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
[January 03, 2014]

Research and Markets: Orthobiologics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/g265wg/orthobiologics) has announced the addition of the "Orthobiologics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering.

Orthobiology is a branch of science that develops bone and tissue replacement materials for fast healing and quick recovery of injured muscles, broken bones, ligaments and tendons. Orthobiologics is considered as a highly lucrative market owing to significant growth opportunities. One of the major driver for the growth of this industry is certain limitations that are associated with autografts and allografts.

The rise in number of spinal fusion surgeries has created the demand for bone graft substitutes and has consequently boosted the overall growth of this industry. In addition, rise in the incidence of arthritis, increase in geriatric population and increase in obesity rate has triggered the growth of this market. Technological advancements, growing demand for minimally invasive procedures and rising patient awareness are the other factors that has considerably augmented the growth of ths market. The global orthobiologics market was valued at USD 3,754.6 million in 2012 and is expected to grow at a CAGR of 5.9% from 2013 to 2019 to reach at an estimated value of USD 5,519.9 million in 2019.



At present, viscosupplementation accounts for the largest share of the orthobiologics market. The growth in this market is attributed to growing popularity of knee treatments and its ability to act as an effective pain killer as compared to NSAIDS and others. This market is followed by bone morphogenetic proteins (BMPs) which is characterized by its ability to provide faster recovery, lesser pain and ability to stimulate patients own cells for regeneration. However, the market is expected to show a negative growth rate during the forecast period due to decline in the sales of 'INFUSE' a Medtronic product. Severe side effects associated with INFUSE due to its heavy off label usage led to recall of this product by the U.S. FDA. Synthetic bone substitutes and stem cell based products are expected to witness a significant growth during the forecast period. The growth of these segments is witnessed due to reduced cost, quick recovery and eliminated risk of disease transmission.

Key Topics Covered


  1. Preface
  2. Executive Summary
  3. Market Overview
  4. Global Orthobiologics Market, by Product
  5. Global Orthobiologics Market, by Application
  6. Global Orthobiologics Market, by Geography
  7. Global Orthobiologics Market Share Analysis
  8. Recommendations
  9. Company Profiles

Companies Mentioned

- Alphatec Spine

- Bacterin International

- Biomet

- DePuy Synthes (A Johnson & Johnson Company)

- Exactech.

- Globus Medical

- Integra LifeSciences Corporation

- Medtronic

- NuVasive

- Orthofix Holdings

- Regeneration Technologies

- Sanofi

- Stryker Corporation

- Wright Medical Technology

- Zimmer Holdings

For more information visit http://www.researchandmarkets.com/research/g265wg/orthobiologics

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.


[ Back To TMCnet.com's Homepage ]